Brief: Infinity Pharmaceuticals Raises $20 Million
09/01/2020 12:50
Jan 9 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS RAISES $20 MILLION THROUGH AN
INNOVATIVE NON-DILUTIVE ASSET-BACKED FINANCING FROM BVF
* INFINITY PHARMACEUTICALS INC - NON-DILUTIVE FINANCING
EXTENDS
CASH RUNWAY INTO 2H 2021
* INFINITY PHARMACEUTICALS - INFINITY RETAINS ITS ABOUT 1%
EQUITY
INTEREST IN PELLEPHARM
* INFINITY PHARMACEUTICALS - NOW HAVE OVER $60 MILLION CASH
ON
HAND TO FUND ALL CURRENT IPI-549 TRIALS TO KEY DATA READOUTS
THROUGHOUT 2020 & INTO H2 2021
* INFINITY - ELIGIBLE TO RECEIVE FROM BVF ADDITIONAL $5
MILLION
PAYMENT UPON POSITIVE DATA FROM PELLEPHARM'S PHASE 3 TRIAL IN
PATIENTS WITH GORLIN SYNDROME
Source text for Eikon: ID:nBw4qFKHxa
Further company coverage: INFI.O
((Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX